NCT01834300

Brief Summary

This project examines the effects of a 4 month structured exercise intervention program in patients with non-alcoholic fatty liver disease (NAFLD). We will examine changes in total and depot-specific (i.e.in different tissues, liver, muscle and pancreas)fat. We will correlate these with measurements of the insulin from the liver. The hypothesis is that by reducing fat in these specific depots we can reduce insulin resistance and prevent progression to diabetes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2009

Longer than P75 for not_applicable

Geographic Reach
1 country

7 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2009

Completed
4.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2013

Completed
11 days until next milestone

First Submitted

Initial submission to the registry

April 12, 2013

Completed
5 days until next milestone

First Posted

Study publicly available on registry

April 17, 2013

Completed
Last Updated

December 18, 2024

Status Verified

May 1, 2024

Enrollment Period

4.2 years

First QC Date

April 12, 2013

Last Update Submit

December 13, 2024

Conditions

Keywords

Hepatic insulin sensitivityMuscle insulin sensitivityB cell functionVLDL1 TG metabolismVLDL2 TG metabolism

Outcome Measures

Primary Outcomes (1)

  • Reduction in liver and muscle fat

    Tissue triglyceride content, or steatosis, will be accurately and non-invasively quantified in vivo using localized proton magnetic resonance spectroscopy (1H MRS).

    4 months

Secondary Outcomes (5)

  • Changes in liver function tests

    4 months

  • Changes in lipid profiles

    4 months

  • Changes in body weight and anthropometric measurements

    4 months

  • Hepatic insulin sensitivity

    4 months

  • VLDL-TG kinetics

    4 months

Study Arms (2)

Control

EXPERIMENTAL

Unsupervised exercise training This group will be given 1 hour lifestyle counseling by the exercise trainer after which they will have no contact with the exercise trainer to the end of the intervention period. The exercise intervention will be offered to the subjects once the post studies are completed.

Behavioral: Unsupervised exercise training

lifestyle counseling and exercise

EXPERIMENTAL

Supervised exercise training Four months exercise training intervention will be either gym-based or patients will choose the mode of exercise that suits their lifestyle. Patients will be encouraged to exercise four times per week for 30-45 min at 60-80 % of maximal heart rate, with a 5 min warm-up and warm-down. Participants will be given free access to a variety of affiliated sports centres and will use the Wellness Key system, a software program that enables researchers to remotely track the exercise activity of participants very accurately. To ensure compliance with rest or exercise, all participants of both groups will have their mean physical activity level in 2 non-consecutive weeks evaluated with an ambulatory accelerometer.

Behavioral: Supervised exercise training

Interventions

The patients will be given lecture on lifestyle changes and its benefitial effects on health at the begining of the study by the exercise trainer. There will be no conatct with the exercise trainer for the period of intervention for 4 months.

Control

Patients will be encouraged to exercise four times per week for 30-45 min at 60-80 % of maximal heart rate, with a 5 min warm-up and warm-down. Participants will be given free access to a variety of affiliated sports centres and will use the Wellness Key system, a software program that enables researchers to remotely track the exercise activity of participants very accurately. To ensure compliance with rest or exercise, all participants of both groups will have their mean physical activity level in 2 non-consecutive weeks evaluated with an ambulatory accelerometer.

lifestyle counseling and exercise

Eligibility Criteria

Age20 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Sedentary, non smoking, male subjects,
  • Alcohol consumption men \<21 units/week,
  • BMI 27-35. (Lean individuals do not suffer from NAFLD, so are not suitable for this study. Conversely, we are restricted to a maximum BMI of 35 due to the size limitations of the MR scanner.)
  • Being willing to engage and motivated to follow an exercise program.

You may not qualify if:

  • Prescription of corticosteroids, amiodarone, tamoxifen, methotrexate (drugs known to cause secondary steatohepatitis) or fibrates. Statin is Ok as long as the patients are on stable therapy for a while, if changed then the patient will be excluded.
  • Alcohol consumption for men 21 units/week.
  • A contraindication to exercise (such as unstable ischaemic heart disease),
  • Type 2 diabetes (type 2 diabetes patients are excluded so that we are examining the involvement of insulin resistance at a reversible stage before β-cell failure has occurred).
  • Patients who are on medications that will interact with GTN (glyceryl trinitrate) will be excluded from the GTN dilatation (endothelial independent NO mediated function) aspect of the study.
  • Individuals who suffer from claustrophobia and have metal implants will be excluded from the MRI aspect of the study.
  • Patients who smoke will also be excluded from the study.
  • Total cholesterol \>7

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (7)

Royal Surrey County Hospital

Guildford, Surrey, GU16 7UJ, United Kingdom

Location

University of Surrey

Guildford, Surrey, GU27WG, United Kingdom

Location

John Moores University

Liverpool, L3 2ET, United Kingdom

Location

University of Liverpool

Liverpool, L69 3GE, United Kingdom

Location

Royal Liverpool University Hospital

Liverpool, L7 8XP, United Kingdom

Location

Liverpool University

Liverpool, L9 7AL, United Kingdom

Location

Imperial College London

London, W12 0HS, United Kingdom

Location

Related Publications (2)

  • Shojaee-Moradie F, Cuthbertson DJ, Barrett M, Jackson NC, Herring R, Thomas EL, Bell J, Kemp GJ, Wright J, Umpleby AM. Exercise Training Reduces Liver Fat and Increases Rates of VLDL Clearance But Not VLDL Production in NAFLD. J Clin Endocrinol Metab. 2016 Nov;101(11):4219-4228. doi: 10.1210/jc.2016-2353. Epub 2016 Sep 1.

  • Pugh CJ, Sprung VS, Jones H, Richardson P, Shojaee-Moradie F, Umpleby AM, Green DJ, Cable NT, Trenell MI, Kemp GJ, Cuthbertson DJ. Exercise-induced improvements in liver fat and endothelial function are not sustained 12 months following cessation of exercise supervision in nonalcoholic fatty liver disease. Int J Obes (Lond). 2016 Dec;40(12):1927-1930. doi: 10.1038/ijo.2016.123. Epub 2016 Jul 21.

MeSH Terms

Conditions

Non-alcoholic Fatty Liver Disease

Condition Hierarchy (Ancestors)

Fatty LiverLiver DiseasesDigestive System Diseases

Study Officials

  • Daniel Cuthbertson, BSc PhD MRCP

    University of Liverpool

    STUDY DIRECTOR
  • Fariba Shojaee-Moradie, BSc PhD

    University of Surrey

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 12, 2013

First Posted

April 17, 2013

Study Start

January 1, 2009

Primary Completion

April 1, 2013

Study Completion

April 1, 2013

Last Updated

December 18, 2024

Record last verified: 2024-05

Locations